Dysregulated miR-155 expression in peripheral blood mononuclear cells from patients with type 2 diabetes

Experimental and Clinical Endocrinology and Diabetes

Volumn 121, Issue 6, 2013, Pages 347-353

  Corral Fernandez N E ^a   Salgado Bustamante, M ^a   Martinez Leija M E ^a   Cortez Espinosa, N ^a   Garcia Hernandez M H ^b   Reynaga Hernandez E ^a   Quezada Calvillo, R ^a   Portales Perez D P ^a  

^a UNIVERSIDAD AUTÓNOMA DE SAN LUIS POTOSÍ   (Mexico)

^b INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

Author keywords

cytokines; inflammation; metabolic control; microRNAs

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; INTERLEUKIN 1BETA; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; MICRORNA 146A; MICRORNA 155; TRIACYLGLYCEROL;

ADULT; AGE DISTRIBUTION; ARTICLE; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DOWN REGULATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MALE; METABOLIC REGULATION; NON INSULIN DEPENDENT DIABETES MELLITUS; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; SEX DIFFERENCE; SUPERNATANT;

ADULT; BLOOD GLUCOSE; BODY MASS INDEX; DIABETES MELLITUS, TYPE 2; DOWN-REGULATION; FEMALE; GENE EXPRESSION REGULATION; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; INTERLEUKIN-1BETA; INTERLEUKIN-6; LEUKOCYTES, MONONUCLEAR; MALE; MICRORNAS; MIDDLE AGED;

EID: 84879116206     PISSN: 09477349     EISSN: 14393646     Source Type: Journal    
DOI: 10.1055/s-0033-1341516     Document Type: Article

References (52)

1. Maraschin J. F., Murussi N., Witter V. et al. Diabetes mellitus classification. Arq Bras Cardiol: 2010; 95 e40 e46
2. Pickup J. C. Inflammation and activated innate immunity in the pathogenesis of type 2 diabetes. Diabetes Care: 2004; 27 813 823
3. Shoelson S. E., Herrero L., Naaz A. Obesity, inflammation, and insulin resistance. Gastroenterology: 2007; 132 2169 2180
4. Kolb H., Mandrup-Poulsen T. An immune origin of type 2 diabetes? Diabetologia: 2005; 48 1038 1050
5. Tilg H., Moschen A. R. Inflammatory mechanisms in the regulation of insulin resistance. Mol Med: 2008; 14 222 231
6. Pillai R. S. MicroRNA function: multiple mechanisms for a tiny RNA? RNA: 2005; 11 1753 1761
7. Friedman J. M., Jones P. A. MicroRNAs: critical mediators of differentiation, development and disease. Swiss Med Wkly: 2009; 139 466 472
8. Li M., Marin-Muller C., Bharadwaj U. et al. MicroRNAs: control and loss of control in human physiology and disease. World J Surg: 2009; 33 667 684
9. Walker M. D. Role of MicroRNA in pancreatic beta-cells: where more is less. Diabetes: 2008; 57 2567 2568
10. Pandey A. K., Agarwal P., Kaur K. et al. MicroRNAs in diabetes: tiny players in big disease. Cell Physiol Biochem: 2009; 23 221 232
11. Gallagher I. J., Scheele C., Keller P. et al. Integration of microRNA changes in vivo identifies novel molecular features of muscle insulin resistance in type 2 diabetes. Genome Med: 2010; 2 9
12. Balasubramanyam M., Aravind S., Gokulakrishnan K. et al. Impaired miR-146a expression links subclinical inflammation and insulin resistance in Type 2 diabetes. Mol Cell Biochem: 2011; 351 197 205
13. O'Connell R. M., Taganov K. D., Boldin M. P. et al. MicroRNA-155 is induced during the macrophage inflammatory response. Proc Natl Acad Sci USA: 2007; 104 1604 1609
14. Tili E., Michaille J. J., Cimino A. et al. Modulation of miR-155 and miR-125b levels following lipopolysaccharide/TNF-alpha stimulation and their possible roles in regulating the response to endotoxin shock. J Immunol: 2007; 179 5082 5089
15. Rodriguez A., Vigorito E., Clare S. et al. Requirement of bic/microRNA-155 for normal immune function. Science: 2007; 316 608 611
16. Taganov K. D., Boldin M. P., Chang K. J. et al. NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proc Natl Acad Sci USA: 2006; 103 12481 12486
17. Pauley K. M., Satoh M., Chan A. L. et al. Upregulated miR-146a expression in peripheral blood mononuclear cells from rheumatoid arthritis patients. Arthritis Res Ther: 2008; 10 R101
18. Schmittgen T. D., Livak K. J. Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc: 2008; 3 1101 1108
19. Herrera B. M., Lockstone H. E., Taylor J. M. et al. MicroRNA-125a is over-expressed in insulin target tissues in a spontaneous rat model of Type 2 Diabetes. BMC Med Genomics: 2009; 2 54
20. Pauley K. M., Satoh M., Chan A. L. et al. Upregulated miR-146a expression in peripheral blood mononuclear cells from rheumatoid arthritis patients. Arthritis Res Ther: 2008; 10 R101
21. Murata K., Yoshitomi H., Tanida S. et al. Plasma and synovial fluid microRNAs as potential biomarkers of rheumatoid arthritis and osteoarthritis. Arthritis Res Ther: 2010; 12 R86
22. Wu F., Zikusoka M., Trindade A. et al. MicroRNAs are differentially expressed in ulcerative colitis and alter expression of macrophage inflammatory peptide-2 alpha. Gastroenterology: 2008; 135 1624 1635
23. Hotamisligil G. S. Inflammation and metabolic disorders. Nature: 2006; 444 860 867
24. O'Connell R. M., Rao D. S., Chaudhuri A. A. et al. Physiological and pathological roles for microRNAs in the immune system. Nat Rev Immunol: 2010; 10 111 122
25. Lodish H. F., Zhou B., Liu G. et al. Micromanagement of the immune system by microRNAs. Nat Rev Immunol: 2008; 8 120 130
26. Ma X., Becker Buscaglia L. E., Barker J. R. et al. MicroRNAs in NF-{kappa}B signaling. J Mol Cell Biol: 2011; 3 159 166
27. Taganov K. D., Boldin M. P., Chang K. J. et al. NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proc Natl Acad Sci USA: 2006; 103 12481 12486
28. Imaizumi T., Tanaka H., Tajima A. et al. IFN-gamma and TNF-alpha synergistically induce microRNA-155 which regulates TAB2/IP-10 expression in human mesangial cells. Am J Nephrol: 2010; 32 462 468
29. Ichimura A., Ruike Y., Terasawa K. et al. MicroRNA-34a inhibits cell proliferation by repressing mitogen-activated protein kinase kinase 1 during megakaryocytic differentiation of K562 cells. Mol Pharmacol: 2010; 77 1016 1024
30. Mudhasani R., Imbalzano A. N., Jones S. N. An essential role for Dicer in adipocyte differentiation. J Cell Biochem: 2010; 110 812 816
31. Kuipers H., Schnorfeil F. M., Fehling H. J. et al. Dicer-dependent microRNAs control maturation, function, and maintenance of Langerhans cells in vivo. J Immunol: 2010; 185 400 409
32. Coley W., Van D. R., Carpio L. et al. Absence of DICER in monocytes and its regulation by HIV-1. J Biol Chem: 2010; 285 31930 31943
33. Sato F., Tsuchiya S., Meltzer S. J. et al. MicroRNAs and epigenetics. FEBS J: 2011; 278 1598 1609
34. Duttagupta R., Jiang R., Gollub J. et al. Impact of Cellular miRNAs on Circulating miRNA Biomarker Signatures. PLoS One: 2011; 6 e20769
35. Klinge CM. Estrogen Regulation of MicroRNA Expression. Curr Genomics: 2009; 10 169 183
36. Noren H. N., Abdelmohsen K., Gorospe M. et al. microRNA expression patterns reveal differential expression of target genes with age. PLoS One: 2010; 5 e10724
37. Garcia-Garcia E., Aguilar-Salinas C. A., Tusie-Luna T. et al. Early-onset type 2 diabetes in Mexico. Isr Med Assoc J: 2002; 4 444 448
38. Jimenez-Corona A., Rojas R., Gomez-Perez F. J. et al. Early-onset type 2 diabetes in a Mexican survey: results from the National Health and Nutrition Survey 2006. Salud Publica Mex: 2010; 52 01 S27 S35
39. Badawi A., Klip A., Haddad P. et al. Type 2 diabetes mellitus and inflammation: Prospects for biomarkers of risk and nutritional intervention. Diabetes Metab Syndr Obes: 2010; 3 173 186
40. Muller S., Martin S., Koenig W. et al. Impaired glucose tolerance is associated with increased serum concentrations of interleukin 6 and co-regulated acute-phase proteins but not TNF-alpha or its receptors. Diabetologia: 2002; 45 805 812
41. Creely S. J., McTernan P. G., Kusminski C. M. et al. Lipopolysaccharide activates an innate immune system response in human adipose tissue in obesity and type 2 diabetes. Am J Physiol Endocrinol Metab: 2007; 292 E740 E747
42. Stegenga M. E., van der Crabben S. N., Dessing M. C. et al. Effect of acute hyperglycaemia and/or hyperinsulinaemia on proinflammatory gene expression, cytokine production and neutrophil function in humans. Diabet Med: 2008; 25 157 164
43. Jagannathan-Bogdan M., McDonnell M. E., Shin H. et al. Elevated proinflammatory cytokine production by a skewed T cell compartment requires monocytes and promotes inflammation in type 2 diabetes. J Immunol: 2011; 186 1162 1172
44. Schroder K., Zhou R., Tschopp J. The NLRP3 inflammasome: a sensor for metabolic danger? Science: 2010; 327 296 300
45. Garcia-Hernandez M. H., Portales-Cervantes L., Cortez-Espinosa N. et al. Expression and function of P2X(7) receptor and CD39/Entpd1 in patients with type 2 diabetes and their association with biochemical parameters. Cell Immunol: 2011; 269 135 143
46. Rayner K. J., Suarez Y., Davalos A. et al. MiR-33 contributes to the regulation of cholesterol homeostasis. Science: 2010; 328 1570 1573
47. Marquart T. J., Allen R. M., Ory D. S. et al. miR-33 links SREBP-2 induction to repression of sterol transporters. Proc Natl Acad Sci USA: 2010; 107 12228 12232
48. Ortega F. J., Moreno-Navarrete J. M., Pardo G. et al. MiRNA expression profile of human subcutaneous adipose and during adipocyte differentiation. PLoS One: 2010; 5 e9022
49. Antuna-Puente B., Feve B., Fellahi S., Bastard J. P. Adipokines: the missing link between insulin resistance and obesity. Diabetes Metab: 2008; 34 2 11
50. Hilton C., Neville M. J., Karpe F. MicroRNAs in adipose tissue: their role in adipogenesis and obesity. Int J Obes (Lond): 2012; 10
51. McGregor R. A., Choi M. S. microRNAs in the regulation of adipogenesis and obesity. Curr Mol Med: 2011; 11 304 316
52. Kloting N., Berthold S., Kovacs P. et al. MicroRNA expression in human omental and subcutaneous adipose tissue. PLoS One: 2009; 4 e4699